These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 5971411)
1. Serum transaminase levels during treatment with isoniazid, streptomycin and PAS. Smith JM; Springett VH Tubercle; 1966 Sep; 47(3):245-9. PubMed ID: 5971411 [No Abstract] [Full Text] [Related]
2. [Thiamine metabolism in children with tuberculosis during therapy with streptomycin, phthivazid and PAS]. Nazarenko GG Pediatriia; 1968 Jan; 47(1):80-4. PubMed ID: 5754014 [No Abstract] [Full Text] [Related]
3. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients]. Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895 [No Abstract] [Full Text] [Related]
4. Rifampin-isoniazid compared with PAS-isoniazid-streptomycin in initial treatment of pulmonary tuberculosis. A controlled cooperative trial. Boman G Chest; 1972 Jun; 61(6):533-8. PubMed ID: 5032151 [No Abstract] [Full Text] [Related]
5. [Comparison of three regimens, INH-SM-PAS, INH-SM-RFP and INH-PAS-RFP, in the original treatment cases of pulmonary tuberculosis. Report of the 13th series study (original treatment study)]. Kekkaku; 1973 Jun; 48(6):235-45. PubMed ID: 4581528 [No Abstract] [Full Text] [Related]
6. Serum transaminase levels in pulmonary tuberculosis. Effect of triple treatment with 4-4 1-di-isoamyloxythiocarbanilide or PAS in combination with streptomycin and isoniazid. Ockerman PA; Ryde C Scand J Respir Dis; 1968; 49(1):35-41. PubMed ID: 5187250 [No Abstract] [Full Text] [Related]
7. The treatment of tuberculosis of the female genital tract with streptomycin, PAS and isoniazid. Sutherland AM Tubercle; 1976 Jun; 57(2):137-44. PubMed ID: 822549 [TBL] [Abstract][Full Text] [Related]
8. The predictability of hypersensitivity to anti-tuberculous drugs. Thompson JE Aust N Z J Med; 1973 Jun; 3(3):239-44. PubMed ID: 4517219 [No Abstract] [Full Text] [Related]
9. Incidence of drug hypersensitivity in the chemotherapy of tuberculosis. Govindaraj M; Grant LJ Br J Dis Chest; 1968 Jan; 62(1):27-31. PubMed ID: 5656836 [No Abstract] [Full Text] [Related]
10. Drugs for tuberculosis. Br Med J; 1968 Sep; 3(5619):664-7. PubMed ID: 4175142 [No Abstract] [Full Text] [Related]
11. A two-year follow-up of 181 sputum-positive tuberculosis patients treated in Gateshead between 1961 and 1966. Pande BR; Martischnig KM; Feinmann L Tubercle; 1970 Mar; 51(1):39-43. PubMed ID: 5495334 [No Abstract] [Full Text] [Related]
12. Co-operative controlled trial of a standard regimen of streptomycin, PAS and isoniazid and three alternative regimens of chemotherapy in Britain. A report from the British Medical Research Council. Tubercle; 1973 Jun; 54(2):99-129. PubMed ID: 4203162 [No Abstract] [Full Text] [Related]
13. [Comparative study of 2 therapeutic schemes in pulmonary tuberculosis not previously treated]. Galleguillos F; Valenzuela P; Carrasco E; Ham O; Ihnen R Rev Med Chil; 1973 Jan; 101(1):25-9. PubMed ID: 4753547 [No Abstract] [Full Text] [Related]
14. Toleration and absorption of sodium para-aminosalicylate and para-aminosalicylic acid (neopasalate). Comparison with other forms of para-aminosalicylic acid. Yue WY; Cohen SS Dis Chest; 1966 Feb; 49(2):165-74. PubMed ID: 5907972 [No Abstract] [Full Text] [Related]
15. Chemotherapy of tuberculosis. I. Typical Mycobacterium tuberculosis--primary drugs. J Kans Med Soc; 1968 Sep; 69(9):445-8. PubMed ID: 4971623 [No Abstract] [Full Text] [Related]
16. [Hepatitis induced by isoniazid]. Noya M; Castillo J; Lema M; Alvarez-Prechous A Rev Clin Esp; 1974 Jun; 133(6):525-30. PubMed ID: 4438705 [No Abstract] [Full Text] [Related]
17. Serum enzyme changes in patients receiving antituberculosis therapy with rifampicin or p-aminosalicylic acid, plus isoniazid and streptomycin. Baron DN; Bell JL Tubercle; 1974 Jun; 55(2):115-20. PubMed ID: 4620296 [No Abstract] [Full Text] [Related]
18. [Effectiveness and possibilities of application to ambulatory patients in our region of a pulmonary tuberculosis therapy by the intermittent administration (I.V.) of the triple association isoniazid-streptomycin-PAS (preliminary results after a year)]. Burghard G; Petitjean R; Schranz J; Scherrer B Rev Tuberc Pneumol (Paris); 1970; 34(3):439-53. PubMed ID: 5515514 [No Abstract] [Full Text] [Related]